RGNX icon

Regenxbio

Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$27
197% upside
High target

4 analyst ratings

positive
neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
HC Wainwright & Co
HC Wainwright & Co
Yi Chen
57% 1-yr RGNX win rate
9 Mar ‘26 1 month ago
Morgan Stanley
Morgan Stanley
Judah Frommer
50% 1-yr RGNX win rate
6 Mar ‘26 1 month ago
Goldman Sachs
Goldman Sachs
Paul Choi
10 Feb ‘26 2 months ago
Chardan Capital
Chardan Capital
Daniil Gataulin
57% 1-yr RGNX win rate
10 Feb ‘26 2 months ago